Literature DB >> 18651145

A case of catastrophic antiphospholipid syndrome presenting with acute respiratory distress syndrome as the initial manifestation.

Kazushi Kinjo1, Hiroya Terabe, Megumi Ogawa, Hideki Takeda, Doki Cho, Shinichi Hoshino, Takeshi Miyahira, Mariko Oshiro.   

Abstract

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). Catastrophic antiphospholipid syndrome (CAPS) is a small subset of APS characterized by widespread systemic thrombotic disease with multiorgan failure. We herein describe an autopsy case of CAPS who developed severe respiratory failure due to acute respiratory distress syndrome (ARDS) as the initial manifestation. Patients with APS may exhibit a broad spectrum of pulmonary diseases. ARDS is the common pulmonary complication in CAPS, although it rarely occurs in APS. Some mechanisms of ARDS in CAPS have been postulated but the precise mechanism is still not clearly understood. It is important to understand that APS or CAPS could be a cause of ARDS since ARDS might develop as the initial manifestation of APS or CAPS as seen in our case. Our case is interesting in that severe respiratory failure due to ARDS was the initial presentation of CAPS.

Entities:  

Mesh:

Year:  2008        PMID: 18651145     DOI: 10.1007/s00296-008-0649-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  19 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

Review 2.  Pulmonary pathology of the adult respiratory distress syndrome.

Authors:  J F Tomashefski
Journal:  Clin Chest Med       Date:  1990-12       Impact factor: 2.878

3.  An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases.

Authors:  S B Ingram; S H Goodnight; R M Bennett
Journal:  Arthritis Rheum       Date:  1987-10

Review 4.  Antiphospholipid syndrome.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Pediatr Clin North Am       Date:  2005-04       Impact factor: 3.278

5.  Pulmonary hypertension in a lupus clinic: experience with twenty-four patients.

Authors:  R A Asherson; T W Higenbottam; A T Dinh Xuan; M A Khamashta; G R Hughes
Journal:  J Rheumatol       Date:  1990-10       Impact factor: 4.666

6.  The intrarenal vascular lesions associated with primary antiphospholipid syndrome.

Authors:  D Nochy; E Daugas; D Droz; H Beaufils; J P Grünfeld; J C Piette; J Bariety; G Hill
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

7.  Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.

Authors:  Maria G Tektonidou; Natassa Varsou; Grigorios Kotoulas; Anna Antoniou; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2006-11-13

Review 8.  The lung in the antiphospholipid syndrome.

Authors:  G Espinosa; R Cervera; J Font; R A Asherson
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

9.  Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome.

Authors:  S Ghosh; H D Walters; J H Joist; T G Osborn; T L Moore
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

10.  Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  R A Asherson; F Lioté; B Page; O Meyer; N Buchanan; M A Khamashta; P Jungers; G R Hughes
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

View more
  1 in total

1.  Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report.

Authors:  Ryo Kaimori; Haruto Nishida; Tomohisa Uchida; Mari Tamura; Kohji Kuroki; Kumi Murata; Kinta Hatakeyama; Yoshihiko Ikeda; Kisaki Amemiya; Akira Nishizono; Tsutomu Daa; Shinjiro Mori
Journal:  Thromb J       Date:  2022-10-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.